Page 1 of Clinical Trials for PDE V Inhibitor, 433 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
Last Updated: August 22, 2008
Condition(s): Erectile Dysfunction; Hypogonadism
2
Completed
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
Last Updated: October 6, 2008
Condition(s): Pharmacokinetics of Three PDE5Is; Healthy Subjects; Genetic Polymorphic CYP3A5
3
Active, not recruiting
Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension
Last Updated: January 11, 2011
Condition(s): Pulmonary Arterial Hypertension
4
Completed
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
Last Updated: January 12, 2012
Condition(s): Erectile Dysfunction; Sexual Dysfunction
5
Completed
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
Last Updated: September 13, 2010
Condition(s): Eisenmenger Syndrome
6
Recruiting
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Last Updated: January 4, 2012
Condition(s): Anterior Ischemic Optic Neuropathy
7
Recruiting
Low Intensity Shock Wave Therapy (LI-ESWT) for Erectile Dysfunction in Post Radical Prostatectomy Patients Not Responding to PDE5 Inhibitors (LI-ESWT)
Last Updated: May 30, 2011
Condition(s): Erectile Dysfunction
8
Not yet recruiting
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
Last Updated: October 20, 2011
Condition(s): Pulmonary Arterial Hypertension
9
Completed
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
Last Updated: June 29, 2009
Condition(s): Erectile Dysfunction
10
Recruiting
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Last Updated: December 14, 2011
Condition(s): Optic Neuropathy, Ischemic
11
Completed
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Last Updated: February 2, 2010
Condition(s): Hypogonadism; Erectile Dysfunction
12
Completed
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)
Last Updated: March 25, 2008
Condition(s): Erectile Dysfunction
13
Completed
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Last Updated: January 11, 2011
Condition(s): Erectile Dysfunction; Cardiovascular Diseases; Male Urogenital Diseases
14
Recruiting
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
Last Updated: January 28, 2011
Condition(s): Raynaud Phenomenon
15
Recruiting
The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Last Updated: January 11, 2007
Condition(s): Hypogonadism; Erectile Dysfunction
16
Recruiting
A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors
Last Updated: December 1, 2011
Condition(s): Nonarteritic Anterior Ischemic Optic Neuropathy
17
Recruiting
Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension (PAH) Therapies
Last Updated: January 11, 2012
Condition(s): Pulmonary Arterial Hypertension
18
Completed
Sildenafil and Exercise Capacity in Hypertension
Last Updated: April 7, 2010
Condition(s): Hypertension
19
Completed
Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors
Last Updated: May 26, 2011
Condition(s): Erectile Dysfunction
20
Not yet recruiting
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
Last Updated: June 25, 2008
Condition(s): Pulmonary Arterial Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=PDE+V+Inhibitor

Page 1 of Clinical Trials for PDE V Inhibitor, 433 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About